Jim Simons Medicinova Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Medicinova Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 178,700 shares of MNOV stock, worth $230,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,700

Previous 181,700 1.65%

Holding current value

$230,523

Previous $265,000 11.7%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$1.2 - $1.56 $3,600 - $4,680	-3,000 Reduced 1.65%	178,700 $234,000
Q1 2025 May 14, 2025	BUY	$1.46 - $2.16 $584 - $864	400 Added 0.22%	181,700 $265,000
Q4 2024 Feb 13, 2025	SELL	$1.53 - $2.38 $8,109 - $12,614	-5,300 Reduced 2.84%	181,300 $380,000
Q3 2024 Nov 13, 2024	SELL	$1.13 - $2.1 $26,441 - $49,140	-23,400 Reduced 11.14%	186,600 $391,000
Q2 2024 Aug 09, 2024	SELL	$1.28 - $1.57 $26,112 - $32,028	-20,400 Reduced 8.85%	210,000 $302,000
Q1 2024 May 13, 2024	BUY	$1.28 - $1.65 $72,064 - $92,895	56,300 Added 32.34%	230,400 $334,000
Q4 2023 Feb 13, 2024	BUY	$1.38 - $2.06 $33,810 - $50,470	24,500 Added 16.38%	174,100 $261,000
Q3 2023 Nov 14, 2023	BUY	$2.01 - $2.6 $5,426 - $7,020	2,700 Added 1.84%	149,600 $313,000
Q2 2023 Aug 11, 2023	BUY	$2.09 - $2.43 $5,225 - $6,075	2,500 Added 1.73%	146,900 $338,000
Q1 2023 May 12, 2023	BUY	$1.95 - $2.54 $4,095 - $5,334	2,100 Added 1.48%	144,400 $312,000
Q4 2022 Feb 13, 2023	SELL	$1.97 - $2.66 $14,775 - $19,950	-7,500 Reduced 5.01%	142,300 $292,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.6 $23,730 - $29,380	-11,300 Reduced 7.01%	149,800 $325,000
Q2 2022 Aug 12, 2022	BUY	$2.31 - $3.14 $26,334 - $35,796	11,400 Added 7.62%	161,100 $408,000
Q1 2022 May 13, 2022	BUY	$2.19 - $2.81 $16,206 - $20,794	7,400 Added 5.2%	149,700 $400,000
Q4 2021 Feb 11, 2022	BUY	$2.61 - $4.42 $34,713 - $58,786	13,300 Added 10.31%	142,300 $381,000
Q3 2021 Nov 12, 2021	SELL	$3.4 - $4.24 $20,740 - $25,864	-6,100 Reduced 4.52%	129,000 $489,000
Q2 2021 Aug 13, 2021	SELL	$3.76 - $5.14 $83,096 - $113,594	-22,100 Reduced 14.06%	135,100 $574,000
Q1 2021 May 13, 2021	SELL	$4.81 - $8.74 $226,550 - $411,654	-47,100 Reduced 23.05%	157,200 $794,000
Q4 2020 Feb 10, 2021	SELL	$5.03 - $6.31 $27,665 - $34,705	-5,500 Reduced 2.62%	204,300 $1.08 Million
Q3 2020 Nov 13, 2020	SELL	$4.67 - $11.0 $64,833 - $152,713	-13,883 Reduced 6.21%	209,800 $1.1 Million
Q2 2020 Aug 13, 2020	SELL	$3.06 - $7.06 $64,924 - $149,792	-21,217 Reduced 8.66%	223,683 $1.21 Million
Q1 2020 May 14, 2020	BUY	$2.9 - $6.97 $604,360 - $1.45 Million	208,400 Added 570.96%	244,900 $911,000
Q4 2019 Feb 13, 2020	BUY	$6.48 - $8.76 $236,520 - $319,740	36,500 New	36,500 $246,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

5.08M

Call Options Held

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $63.3M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account